• Campus Header
  • Institute Header
Home
Academics

Integrated first degree

B.E.(Chemical)
B.E.(Civil)
B.E.(Computer Science)
B.E.(Electrical and Electronics)
B.E.(Electronics and Communication)
B.E.(Electronics and Instrumentation)
B.E.(Mechanical)
B.Pharm.(Pharmacy)
M.Sc.(Biological Sciences)
M.Sc.(Chemistry)
M.Sc.(Economics)
M.Sc.(Mathematics)
M.Sc.(Physics)

Higher Degree

M.E.(Biotechnology)
M.E.(Chemical)
M.E.(Civil with specialization in Structural Engineering)
M.E.(Civil with specialization in Transportation Engineering)
M.E.(Communication Engineering)
M.E.(Computer Science)
M.E.(Design Engineering)
M.E.(Embedded Systems)
M.E.(Manufacturing Systems Engineering)
M.E.(Mechanical)
M.E. (Microelectronics)
M.E. (Sanitation Science, Technology and Management)
M.Pharm.(Pharmacology)
M.Pharm.(Pharmaceutics)
M.E.(Mechanical with specialization in Thermal Engineering)
M.E.(Environmental Engineering)

Doctoral Programmes

Biological Sciences
Chemical Engineering
Chemistry
Civil Engineering
Computer Science & Information Systems
Economics & Finance
Electrical & Electronics Engineering
Humanities & Social Sciences
Mathematics
Mechanical Engineering
Pharmacy
Physics
Departments
Research & Innovation
Centers
Students
Admission
DIVISIONS
QUICK LINKS
Campus
Pilani
Dubai
K K Birla Goa
Hyderabad
BITSoM, Mumbai
BITS Law School, Mumbai
Links For
BITS Library
Admissions
Faculty
Practice School
Placements
Student Arena
Career
News
Alumni
Internationalization
Events
MOUs
Current Students
Invest in Leaders
Outreach
Picture Gallery
Admission
Integrated first degree
Higher degree
Doctorol programmes
International Admissions
Online Admissions
BITSAT
IMPORTANT CONTACTS
Pilani
Dubai
Goa
Hyderabad
RESEARCH & INNOVATION
Overview
Sponsored Research Projects
Consultancy Based Projects
Patents
Publications
R&D Centers
DEPARTMENTS
Pilani
Dubai
Goa
Hyderabad
Academics

Integrated First Degree

B.E.(Biotechnology)
B.E.(Chemical)
B.E.(Civil)
B.E.(Computer Science)
B.E.(Electrical and Electronics)
B.E.(Electronics and Communication)
B.E.(Electronics and Instrumentation)
B.E.(Manufacturing Engineering)
B.E.(Mechanical)
B.Pharm.(Pharmacy)
M.Sc.(Biological Sciences)
M.Sc.(Chemistry)
M.Sc.(Economics)
M.Sc.(General Studies)
M.Sc.(Mathematics)
M.Sc.(Physics)
B.E. (Mathematics and Computing)

Higher Degree

MBA (Master of Business Administration in Business Analytics)
MBA (Master of Business Administration)
M.E.(Electrical with specialization in Power Electronics and Drives)
MBA (Master of Business Administration)
M.E. Civil – Water Resource Engineering
M. E. Computer Science with Specialization in Information Security with B.Sc. input
M.E. (Mechanical with specialization in Thermal Engineering)
M.E. Chemical Engineering (with specialization in Petroleum Engineering)
M.E. Electronics & Control
M.E. M.Pharm
M.E.(Biotechnology)
M.E.(Chemical)
M.E.(Civil with specialization in Infrastructure Engineering and Management)
M.E.(Civil with specialization in Structural Engineering)
M.E.(Civil with specialization in Transportation Engineering)
M.E.(Communication Engineering)
M.E.(Computer Science)
M.E.(Design Engineering)
M.E.(Embedded Systems)
M.E.(Manufacturing Systems Engineering)
M.E.(Mechanical)
M.E.(Microelectronics)
M.E.(Sanitation Science, Technology and Management)
M.E.(Software Systems)
M.Pharm.(Pharmaceutical Chemistry)
M.Pharm.(Pharmaceutics)
M.Pharm.(Pharmacology)
M.Pharm.(Pharmacy)
M.Sc. General Studies – Communication and Media Studies Stream
Master in Public Health
MBA(Master of Business Administration In Business Analytics)

Doctoral Programmes

Biological Sciences
Chemical Engineering
Chemistry
Civil Engineering
Computer Science & Information Systems
Economics & Finance
Electrical & Electronics Engineering
Humanities & Social Sciences
Management
Mathematics
Mechanical Engineering
Pharmacy
Physics
General Sciences

WILP

Dubai Campus

Integrated First Degree
Higher Degree
Doctoral Programmes
Explore BITS
About
Legacy
Achievements
Social Responsibility
Sustainability
Divisions
Pilani
K K Birla Goa
Hyderabad
Dubai
follow us
  • linkedin
  • twitter
  • facebook
  • youtube
  • instagram
Feedback

Prof. Ahmed Kamal 

hyderabad Pharmacy

Sr. Professor Emeritus,
Department of Pharmacy

Design and synthesis of gene-targeting compounds as new and novel anticancer agents, Multi-disciplinary research programmes including organic synthesis, and their targeted delivery as prodrugs, combinatorial and green chemistry including chemical biology and biocatalysis, medicinal
Birla Institute of Technology & Science, Pilani
Hyderabad Campus
Jawahar Nagar, Kapra Mandal
Dist.-Medchal-500 078
Telangana, India
ahmedkamal@hyderabad.bits-pilani.ac.in
ahmedkamal915@gmail.com
+91 40 66303787
+91 9440802784

Recent Publications

  1. An update on the development on tubulin inhibitors for the treatment of solid tumors. Yakkala, P.A.; Rahaman, S.; Soukya, P.S.L.; Begum, S.A.; Kamal, A. Expert Opinion on Therapeutic Targets 2024, 28, 193-220 (Invited Review).
  2. Oxindoline containing thiazolidine-4-one tethered triazoles act as antimitotic agents by targeting microtubule dynamics. Shahjahan, S.; Naraharisetti, L.T.; Begum, A.; Yakkala, P.A.; Soukya, P.S.L.; Godugu, C.; Begum, S.A.; Kamal, A. ChemistrySelect 2024, 9, e202400539
  3. PI3K and Tankyrase Inhibitors as Therapeutic Targets in Colorectal Cancer. Yakkala, P.A.; Naaz, F.; Shafi, S.; Kamal, A. Expert Opinion on Therapeutic Targets 2024, 28, 159-177 (Invited Review).
  4. Converging thiolactone and quinoline scaffolds: New potential antitubercular conjugates. Azeeza, S.; Malik, M.S.; Alsimaree, A.A.; Khan, I.A.; Abdullah, S.T.; Jamal, Q.M.S.; Alzahrani, A.Y.A.; Moussa Z.; Asghar, B.H.; Ahmed, S.A.; Kamal, A. J. Mol. Structures 2024, 1300, 137255.
  5. Prospects of Topoisomerase Inhibitors as Promising Anti-Cancer Agents. Yakkala, P.A.; Penumallu, N.R.; Shafi, S.; Kamal, A. Pharmaceuticals, 2023, 16, 1456 (Invited Review).
  6. Multicomponent Domino Reaction for Concise Access to 2‑Amino-Substituted 1,3,4-Oxadiazoles via Smiles Rearrangement. Yakkala, P.A.; Khan, I.A.; Dannarm, S.R.; Aboti, J.; Sonti, R.; Shafi, S.; Kamal, A. J. Org. Chem. 2023, 88, 12216.
  7. Synthesis, biological evaluation and mechanistic studies of 4-(1,3-thiazol-2-yl)morpholine-benzimidazole hybrids as a new structural class of antimicrobials. Aaghaz, S.; Chander S. Digwal, C.S.; Naziya Neshat, N.; Indresh K. Maurya,
    I.K.; Vinod Kumar, V.; Kulbhushan Tikoo, K.; Jain, R.; Kamal, A. Bioorg. Chem. 2023, 136, 106538.
  8. What are the challenges involved in the strategies for future antibody-drug conjugate discovery and development for oncology? Begum, S.A..; Kamal, A., Expert Opinion on Drug Discovery, 2023, 18, 591 (Invited Review).
  9. Benzimidazole‑linked pyrazolo[1,5‑a]pyrimidine conjugates: synthesis and detail evaluation as potential anticancer agents. Bagul, C.; Rao, G.K.; Veena, I.; Kulkarni, R.; Tamboli, J.R.; Akunuri, R.; Shaik S.P.; Bhadra M.P.; Kamal, A., Mol. Diversity 2023, 27, 1185.
  10. Antibacterial Properties and Computational Insights of Potent Novel Linezolid-Based Oxazolidinones. Malik, M.S.; Faazil, S.; Alsharif, M.A.; Jamal, Q.M.S.; Al-Fahemi, J.H.; Benerji, A.; Chattopadhyay, A.; Pal, S.K.; Kamal, A.; Ahmed, S.A., Pharmaceuticals 2023, 16, 516.
  11. Pyridine-Based 1,2,4-Triazolo-Tethered Indole Conjugates Potentially Affecting TNKS and PI3K in Colorectal Cancer. Yakkala, P.A.; Panda, S.R.; Naidu, V.G.M.; Shafi, S.; Kamal, A., ACS Med. Chem. Lett. 2023, 14, 260.
  12. New quinoline-thiolactone conjugates as potential antitubercular and antibacterial agents. Faazil, S.; Malik, M.S.; Ahmed, S.A.; Jamal, Q.M.S.; Basha, S.T.; Qurban, J.; Asghar, B. H.; Obaid, R.J.; Shaikh, I.N.; Kamal, A., J. Mol. Structures 2023, 1271, 134099.
  13. Synthesis and cytotoxic activity of 1,2,4-triazolo-linked bis-indolyl conjugates as dual inhibitors of tankyrase and PI3K. Yakkala, P.A.; Panda, S.R.; Shafi, S.; Naidu, V.G.M.; Shahar Yar, M.; Ubanako, P.N.; Adeyemi, S.A.; Kumar, P.; Choonara, Y.E.; Radchenko, E.V.; Palyulin, V.A.; Kamal, A., Molecules 2022, 27, 7642.
  14. COVID-19: vaccines and therapeutics, Ponnampalli, S.; Birudukota, N.V.S.; Kamal, A., Bioorg. Med. Chem. Lett. 2022, 75, 128987.
  15. Novel linezolid-based oxazolidinones as potent anticandidiasis and antitubercular agents Faazil, S.; Malik, M.S.; Ahmed, S.A.; Alsantali, R.I.; Yedla, P.; Alsharif, M.A.; Shaikh, I.N.; Kamal, A., Bioorg. Chem. 2022, 126, 105869.
  16. Novel approaches to the development of direct KRAS inhibitors: Structural insight and drug design. Sharma, A.; Yakkala, P.A.; Yar, M.S.; Shafi, S.; Kamal, A., Expert Opinion on Drug Discovery, 2022, 17, 247 (Invited Review).
  17. Synthesis and characterization of novel combretastatin analogues of 1,1 diaryl vinyl sulfones, with antiproliferative potential via in silico and in vitro studies. Egharevba, G.; Kamal, A.; Dosumu, O.; Routhu S.; Fadare O.; Oguntoye S.; Njinga S.; Oluyori, A., Scientific Reports., 2022, 12, 1901.
Complete list of Publications

Keep Exploring

Faculty
Events
News